Skip to content
PeptideAgent

Clinics in New York

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

What New York law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

New York at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified clinics serving New York

No verified clinics serving New York are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in New York

Yes. A New York resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a New York-licensed prescriber, including by telehealth under Public Health Law Article 29-G, which covers telemedicine, store-and-forward technology, remote patient monitoring, and audio-only calls. A compounded peptide is available when it is eligible under federal 503A rules and dispensed by a pharmacy registered by the New York State Education Department on the advice of the State Board of Pharmacy; any pharmacy or outsourcing facility outside New York that ships prescription drugs to New York patients must register as a nonresident establishment under Education Law section 6808-b. [1] [2] [3] [4] [5] [6] [7] [8]

Compounded GLP-1 access in New York

A telehealth GLP-1 program shipping into New York must use a pharmacy registered as a nonresident establishment under Education Law section 6808-b, which patients can verify on the Office of the Professions license lookup. [4] [9]

Research use only sellers in New York

Education Law Article 137 limits dispensing of prescription drugs to registered pharmacies and licensed practitioners, and section 6808-b requires registration of any out-of-state establishment shipping prescription drugs into New York, including internet sellers. [4] [10]

New York notes on specific peptides

  • Semaglutide: Available branded by prescription, including from a New York-licensed telehealth provider under Public Health Law Article 29-G. Compounded semaglutide is limited to the federal patient specific exception since April 22, 2025. [2] [9]
  • Tirzepatide: Available branded by prescription. Compounded tirzepatide is limited to the federal patient specific exception since February 18, 2025, and an out-of-state pharmacy must be registered under Education Law section 6808-b to ship it into New York. [4] [9]

How to check a clinic in New York

  1. Confirm the prescribing clinician's license with the New York medical or nursing board.
  2. Ask which pharmacy compounds or dispenses the peptide and check it in the New York State Board of Pharmacy (State Education Department, Office of the Professions) license lookup. [1] [4] [5] [6] [7] [8]
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in New York. [4] [10]

Common questions in New York

Can I get a GLP-1 prescription in New York through telehealth?

Yes, from a New York-licensed provider. Public Health Law Article 29-G recognizes telemedicine, store-and-forward, remote monitoring, and audio-only calls, and semaglutide and tirzepatide are not controlled substances. [2]

All peptide legal questions for New York

Sources

  1. [1]New York State Education Department, Office of the Professions: Pharmacy
  2. [2]New York Public Health Law Article 29-G, Telehealth delivery of services
  3. [3]New York Public Health Law section 2999-cc, Telehealth definitions
  4. [4]New York Education Law section 6808-b, Registration of nonresident establishments
  5. [5]8 NYCRR 63.8, Registration of nonresident establishments
  6. [6]8 NYCRR Part 63, Pharmacy (Regulations of the Commissioner of Education, including 63.7 continuing education)
  7. [7]8 NYCRR Part 29, Unprofessional conduct (section 29.2, general provisions for health professions)
  8. [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  9. [9]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  10. [10]21 U.S.C. 331, Prohibited acts